Literature DB >> 9740687

Ovarian metastasis in endometrial carcinoma.

N Takeshima1, Y Hirai, K Yano, N Tanaka, K Yamauchi, K Hasumi.   

Abstract

A retrospective study was conducted to investigate the clinical significance of ovarian metastasis in 439 patients with clinical stage I endometrial cancer surgically treated by performing total abdominal hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymphadenectomy. Histologic examination revealed that 22 patients (5%) had ovarian metastasis. The maximum diameter of the ovarian metastases ranged from 1 to 100 mm. In 18.2% (4/22) of patients with ovarian metastasis, the maximum diameter was less than 2 mm. Patients with metastasis limited to the ovarian surface showed 100% positive peritoneal cytology, 0% lymph node metastases, and 50% recurrence, while patients with metastasis inside the ovary showed 10% positive peritoneal cytology, 36% lymph node metastases, and 53% recurrence. The prognosis of patients with ovarian metastasis alone was situated midway between that of patients with cancer limited to the uterus and that of patients with lymph node metastasis alone. The lymph node status was of importance to determine the prognosis of patients with ovarian metastasis. The series also suggests that there may be two routes for ovarian metastasis; one is a route via the fallopian tube to the ovarian surface and the other is a route via the lymphatics to the inside of the ovary. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9740687     DOI: 10.1006/gyno.1998.5086

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

1.  Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival.

Authors:  Tanja Ignatov; Holm Eggemann; Elke Burger; Olaf Ortmann; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-14       Impact factor: 4.553

2.  Premenopausal early-stage endometrial carcinoma patients with low CA-125 levels and low tumor grade may undergo ovary-saving surgery.

Authors:  Seung-Chul Yoo; Jong-Hyuck Yoon; Woo Young Kim; Suk-Joon Chang; Hee-Jae Joo; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

3.  Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only.

Authors:  Jan J Jobsen; Lambert Naudin Ten Cate; Marnix L M Lybeert; Astrid Scholten; Elzbieta M van der Steen-Banasik; Job van der Palen; Marika C Stenfert Kroese; Annerie Slot; Eltjo M J Schutter; Sabine Siesling
Journal:  Obstet Gynecol Int       Date:  2011-05-04

Review 4.  Hysteroscopic surgery for conservative management in endometrial cancer: a review of the literature.

Authors:  Sonsoles Alonso; Teresa Castellanos; Fernando Lapuente; Luis Chiva
Journal:  Ecancermedicalscience       Date:  2015-02-03

Review 5.  Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.

Authors:  Qing Zhang; Gonghua Qi; Margaux J Kanis; Ruifen Dong; Baoxia Cui; Xingsheng Yang; Beihua Kong
Journal:  Oncotarget       Date:  2017-05-03

6.  Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.

Authors:  Umberto Leone Roberti Maggiore; Fabio Martinelli; Giulia Dondi; Giorgio Bogani; Valentina Chiappa; Maria Teresa Evangelista; Viola Liberale; Antonino Ditto; Simone Ferrero; Francesco Raspagliesi
Journal:  J Gynecol Oncol       Date:  2019-02-26       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.